CUE
Cue Biopharma
25.60$
+1.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 83.5% | 83.6% | 82.8% | 80.1% | 83.1% | 78.1% | 71.6% | 75.8% | 81.6% | 87.6% | 85.5% | 86.7% | |
| 79.4% | 78.8% | 76.0% | 70.9% | 72.3% | 69.8% | 59.0% | 67.5% | 37.0% | 64.3% | 53.0% | 56.6% | |
| 79.4% | 78.8% | 76.0% | 70.9% | 72.3% | 69.8% | 59.0% | 67.5% | 59.0% | 64.3% | 53.0% | 56.6% | |
| 2.4% | 2.8% | 2.6% | 4.4% | 7.0% | 2.9% | 0.0% | 1.3% | 7.2% | 17.6% | 23.5% | 23.7% | |
| – | 0.0% | 0.0% | – | – | – | – | – | – | – | – | – | |
| 38.1% | 39.7% | 44.3% | 48.9% | 43.4% | 45.6% | 70.4% | 55.4% | 58.1% | 37.4% | 30.0% | 92.5% | |
| 25.0% | 27.8% | 33.5% | 38.9% | 37.5% | 42.5% | 69.6% | 47.3% | 49.1% | 32.0% | 23.9% | 69.1% | |
| 10.7% | 11.9% | 13.3% | 16.6% | 15.3% | 24.5% | 31.2% | 11.1% | 11.0% | 4.5% | 5.1% | 5.3% | |
| 3.6% | 5.7% | 7.3% | 9.2% | 14.4% | 8.8% | 17.0% | 8.9% | 7.4% | 9.4% | 10.8% | 12.2% | |
| 7.5% | 6.8% | 6.0% | 5.4% | 3.0% | – | – | – | – | – | – | – | |
| 61.9% | 60.3% | 55.7% | 51.1% | 56.6% | 54.4% | 29.6% | 44.6% | 41.9% | 62.6% | 70.0% | 7.5% | |
| -417.7% | -489.5% | -581.2% | -764.7% | -741.7% | -1,062.0% | -1,591.3% | -890.8% | -1,169.4% | -872.9% | -1,210.1% | -1,715.3% | |
| 2.2% | 2.6% | 3.1% | 4.0% | 3.8% | 7.7% | 11.1% | 7.8% | 10.6% | 8.7% | 15.6% | 20.6% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.